Phase 1B/2 Study Of Ladiratuzumab Vedotin (Lv) In Combination With Pembrolizumab For First-Line Treatment Of Triple-Negative Breast Cancer (Sgnlva-002, Trial In Progress)
Ladiratuzumab Vedotin;Pembrolizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase 1B/2 Study Of Ladiratuzumab Vedotin (Lv) In Combination With Pembrolizumab For First-Line Treatment Of Triple-Negative Breast Cancer (Sgnlva-002, Trial In Progress) ### Output: Ladiratuzumab Vedotin;Pembrolizumab